CRDF
#4206
Cardiff Oncology, Inc. - Common Stock
0.8 9 USD
-0.32%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-32.06%
Monthly Change
-28.80%
6 month change
-67.87%
Year Change
-80.09%
Previous Close
1.3 1
Open
0.8 9
Low
0.8 9
High
0.8 9
Volume
17
Financials
- Market Capitalization 60.85 M
- Employee 31
- Founded 1999
- CEO Mark Erlander
- Website www.cardiffoncology.com
- Headquarter Delaware, United States
- FIGI BBG000PXLKM7
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-2.42
Price to sales ratio
206.41
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4201 |  CING Cingulate Inc. - Common Stock | 4.59 USD | -2.55% | -6.33% | -5.94% | -25.49% | 60.94 M USD | ||
| 4204 |  EDSA Edesa Biotech, Inc. - Common Shares | 6.87 USD | +1.93% | -6.15% | +9.22% | +209.46% | 61.09 M USD | ||
| 4225 |  ELTX Elicio Therapeutics, Inc. - Common Stock | 3.04 USD | -2.25% | -12.64% | -3.49% | -69.60% | 58.02 M USD | ||
| 4230 |  CNTX Context Therapeutics Inc. - Common Stock | 0.63 USD | +1.61% | +5.00% | -5.97% | -24.10% | 57.88 M USD |
Frequently asked questions about Cardiff Oncology, Inc. - Common Stock
What is the Cardiff Oncology, Inc. - Common Stock stock price today?
The current price of Cardiff Oncology, Inc. - Common Stock (CRDF) is 0.89. Over the past 24 hours, the stock has changed by -32.06%. Follow the CRDF chart for real-time price dynamics.
What is the stock ticker of Cardiff Oncology, Inc. - Common Stock?
Cardiff Oncology, Inc. - Common Stock trades under the ticker CRDF. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Cardiff Oncology, Inc. - Common Stock stock going up?
CRDF has changed by -28.80% over the last week, -28.80% over the last month, and -80.09% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Cardiff Oncology, Inc. - Common Stock net income for the last quarter?
Cardiff Oncology, Inc. - Common Stock reported net income of -12.35 M for the last quarter. The previous quarter showed -7.22 M, which means net income changed by -71.08%.
How many employees does Cardiff Oncology, Inc. - Common Stock have?
As of the latest available data, Cardiff Oncology, Inc. - Common Stock has 31 employees. Workforce size can provide additional context about the company's scale and operations.
What is Cardiff Oncology, Inc. - Common Stock EBITDA?
Cardiff Oncology, Inc. - Common Stock EBITDA is -12.76 M, and its EBITDA margin is -31.13 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Cardiff Oncology, Inc. - Common Stock stock?
You can buy Cardiff Oncology, Inc. - Common Stock (CRDF) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Cardiff Oncology, Inc. - Common Stock stock?
Investing in Cardiff Oncology, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the CRDF chart and related analysis on metatrader.com as part of your research.